Showing 341 - 360 results of 105,385 for search '(( 2 w decrease ) OR ( 5 ((((non decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.73s Refine Results
  1. 341
  2. 342

    Multiple C–H Activations of Linear Alkanes by Various (η<sup>5</sup>‑Cyclopentadienyl)W(NO)(CH<sub>2</sub>CMe<sub>3</sub>)<sub>2</sub> Complexes by Monica V. Shree (4092343)

    Published 2017
    “…As illustrated in the accompanying diagram, thermolysis of Cp*W­(NO)­(CH<sub>2</sub>CMe<sub>3</sub>)<sub>2</sub> (Cp* = η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>) at 80 °C in neat linear alkanes effects three successive C–H bond activations of the hydrocarbon substrates and forms Cp*W­(NO)­(H)­(η<sup>3</sup>-allyl) complexes in which the allyl ligands are derived from the alkanes. …”
  3. 343

    Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

    Published 2025
    “…<p><b>(A)</b> Manhattan plot of minJSW decrease at 24 months. …”
  4. 344
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350
  11. 351
  12. 352

    MMR mutants show decreased mating-type silencing. by Qian Liu (135614)

    Published 2020
    “…<b>(F</b>) Decreased telomere silencing in the <i>MSH2</i> mutants were rescued by overexpressed <i>MSH2</i>. …”
  13. 353
  14. 354

    Netrin-1 overexpression increases HCV RNA and specific infectivity of HCV virions in vitro whereas Netrin-1 depletion decreases HCV RNA and specific infectivity in vitro. by Marie-Laure Plissonnier (337713)

    Published 2016
    “…Netrin-1 depletion impedes HCV. Huh7.5 cells were transfected with siRNAs, infected at a MOI of 0.1 24 h after seeding, and trypsinized at day five post-infection before a second siRNA transfection. …”
  15. 355
  16. 356

    Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

    Published 2010
    “…<p>(<b>A</b>) Cortex from E14.5 Axin2-d2EGFP transgenic mice stained for GFP (green), Tbr2 (red), and DNA (blue). …”
  17. 357
  18. 358

    The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution. by Pia Steensland (362091)

    Published 2013
    “…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”
  19. 359
  20. 360

    Table_1_v2_A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study.docx by Bin Liu (5899)

    Published 2022
    “…After adjusting for other confounders, the waiting time was identified as an independent prognostic factor.</p>Conclusions<p>A long waiting time before treatment may decrease the survival of stage IA1 NSCLC patients. …”